Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Closets for Your Room: Plan and Utility Features - 2The most effective method to Explore Moral Situations in Brain research with Your Certification
- 3Electric discovery on Mars! Scientists find tiny lightning bolts coming from Red Planet dust clouds
- 4Criminal Guard Lawyer Expenses: What Would it be advisable for you to Hope to Pay?
- 5A definitive Manual for Internet Mastering and Expertise Improvement
- 10 Activities to Lift Your Consume and Bust Your Stomach
- Santa's sleigh or the International Space Station? How to spot a bright Christmas flyby Dec. 24 and 25
- Saturn shines with the waxing moon at sunset on Nov. 29
- I binged all 24 Hallmark Christmas movies in less than 30 days. I emerged a changed man.
- Nikki Glaser returns as host of the 2026 Golden Globes: Everything the comedian has said about the upcoming awards show
- Federal judge upholds Hawaii's new climate change tax on cruise passengers
- Aluminum salts emerge as likely target as health officials scrutinize childhood vaccines
- Wedding trip Objections in the US
- Protest inspired by 'Gen Z' movement draws few young people in Mexico and many government critics
